Evidence map›Paper›PMID 36472801›Full record

ArticlePhysical and engineering sciences in medicine2023

Can magnetic resonance imaging after cranioplasty using titanium mesh detect brain tumors?

Yasuo Takatsu, Rei Yoshida, Yuya Yamatani, Mikihisa Kanno, Tosiaki Miyati

Abstract read
PubMed Publisher
In one paragraph

Article in Physical and engineering sciences in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yasuo TakatsuMolecular Imaging, School of Medical Sciences, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan. pcblue2@yahoo.co.jp.ORCID http://orcid.org/0000-0002-4384-089X
Rei YoshidaDepartment of Radiology, Kurihara Central Hospital, 3-3-1 Miyano chuo, Tsukidate, Kurihara-city, Miyagi, 987-2205, Japan.
Yuya YamataniDivision of Central Radiology, Nara Medical University Hospital, 840, Shijo-Cho, Kashihara, Nara, 634-8522, Japan.
Mikihisa KannoDepartment of Radiological Technology, Minami Matsuyama Hospital, 3-10, Asodamachi, Matsuyama, Ehime, 790-8534, Japan.
Tosiaki MiyatiDivision of Health Sciences, Graduate School of Medical Sciences, Kanazawa University, 5-11-80 Kodatsuno, Kanazawa, 920-0942, Japan.
Kanazawa University · JPNara Medical University Hospital · JPSaiseikai Matsuyama Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study determined the dependence of the concentration and position of contrast-enhanced tumors on the radio frequency (RF)-shielding effect of titanium mesh using the contrast-to-noise ratio (CNR) in magnetic resonance imaging (MRI). A phantom was constructed by filling a plastic container with manganese chloride tetrahydrate and agar. Four cellophane cylindrical containers were arranged from the end of the plastic container, and the brain tumor model was filled with gadobutrol diluted with NaCl, with molarity values of 0.2-1.0 mmol/L. The titanium mesh board was set on the left side of the phantom. Images were acquired using a 1.5-T MRI as well as two-dimensional spin-echo (2D SE) and three-dimensional fast spoiled gradient echo (3D FSPGR) sequences. CNR was calculated using the signal intensity values of the tumor model, surrounding area of the brain model, and background noise. Furthermore, the fractional change in CNR was calculated using values of CNR with and without the mesh. Moreover, a profile of CNR was created. The fractional change in CNR decreased at the brain tumor positions present near the mesh and at a contrast medium concentration of approximately ≤ 0.5 mmol/L in 2D SE and ≤ 0.25 mmol/L in 3D FSPGR. According to the CNR profiles, directly under the mesh, almost all contrast concentrations in 2D SE was unrecognizable; however, at a concentration of ≥ 0.5 mmol/L in 3D FSPGR was recognizable.

Indexed as

Brain NeoplasmsTitaniumBrainHumansMagnetic Resonance ImagingPhantoms, ImagingTitaniumBrain tumorMagnetic resonance imagingPhantomRF-shielding effectTitanium mesh

Identifiers

PMID36472801
OpenAlexW4310778884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.